Detection of Mycobacterium tuberculosis peptides in the exosomes of patients with active and latent M. tuberculosis infection using MRM-MS

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Kruh Garcia, Nicole A ^a   Wolfe, Lisa M ^a   Chaisson, Lelia H ^b   Worodria, William O ^c   Nahid, Payam ^b   Schorey, Jeff S ^d   Davis, J Lucian ^b   Dobos, Karen M ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MAKERERE UNIVERSITY   (Uganda)

^d UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; ANTIGEN 85B; ANTIGEN 85C; APA PROTEIN; BACTERIAL PROTEIN; BFRB PROTEIN; GLCB PROTEIN; HSPX PROTEIN; KATG PROTEIN; MPT64 PROTEIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; PEPTIDE FRAGMENT; PROTEOME;

ADULT; ARTICLE; CONTROLLED STUDY; EXOSOME; EXTRAPULMONARY TUBERCULOSIS; HUMAN; LATENT TUBERCULOSIS; LUNG TUBERCULOSIS; MASS SPECTROMETRY; MULTIPLEXED MULTIPLE REACTION MONITORING MASS SPECTROMETRY; NONHUMAN; PROTEOMICS; SPUTUM SMEAR; TUBERCULOSIS; AMINO ACID SEQUENCE; BLOOD; METABOLISM; MOLECULAR GENETICS; PROSPECTIVE STUDY;

ADULT; AMINO ACID SEQUENCE; BACTERIAL PROTEINS; BIOLOGICAL MARKERS; EXOSOMES; HUMANS; LATENT TUBERCULOSIS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; PROTEOME;

EID: 84905124450     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103811     Document Type: Article

References (39)

1. Steingart KR, Ng V, Henry M, Hopewell PC, Ramsay A, et al. (2006) Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis 6: 664-674. (Pubitemid 44462695)
2. Shingadia D, Novelli V (2003) Diagnosis and treatment of tuberculosis in children. Lancet Infect Dis 3: 624-632. (Pubitemid 37210226)
3. Hargreaves NJ, Kadzakumanja O, Whitty CJ, Salaniponi FM, Harries AD, et al. (2001) 'Smear-negative' pulmonary tuberculosis in a DOTS programme: poor outcomes in an area of high HIV seroprevalence. Int J Tuberc Lung Dis 5: 847-854. (Pubitemid 32843679)
4. Siddiqi K, Lambert ML, Walley J (2003) Clinical diagnosis of smear-negative pulmonary tuberculosis in low-income countries: the current evidence. Lancet Infect Dis 3: 288-296. (Pubitemid 36565881)
5. Behr MA, Warren SA, Salamon H, Hopewell PC, Ponce de Leon A, et al. (1999) Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet 353: 444-449. (Pubitemid 29067335)
6. WHO (2011) Commercial Serodiagnostic Tests for Diagnosis of Tuberculosis: Policy Statement. Geneva: World Health Organization.
7. Pieper R, Gatlin CL, Makusky AJ, Russo PS, Schatz CR, et al. (2003) The human serum proteome: display of nearly 3700 chromatographically separated protein spots on two-dimensional electrophoresis gels and identification of 325 distinct proteins. Proteomics 3: 1345-1364. (Pubitemid 36929557)
8. Mahanty S, Bausch DG, Thomas RL, Goba A, Bah A, et al. (2001) Low levels of interleukin-8 and interferon-inducible protein-10 in serum are associated with fatal infections in acute Lassa fever. J Infect Dis 183: 1713-1721. (Pubitemid 32523233)
9. King HW, Michael MZ, Gleadle JM (2012) Hypoxic enhancement of exosome release by breast cancer cells. BMC Cancer 12: 421.
10. Schorey JS, Bhatnagar S (2008) Exosome function: from tumor immunology to pathogen biology. Traffic 9: 871-881. (Pubitemid 351639493)
11. Beatty WL, Russell DG (2000) Identification of mycobacterial surface proteins released into subcellular compartments of infected macrophages. Infection and immunity 68: 6997-7002. (Pubitemid 32463413)
12. Giri PK, Kruh NA, Dobos KM, Schorey JS (2010) Proteomic analysis identifies highly antigenic proteins in exosomes from M. tuberculosis-infected and culture filtrate protein-treated macrophages. Proteomics 10: 3190-3202.
13. Kruh-Garcia NA SJ, Dobos KM (2012) Exosomes: New Tuberculosis Biomarkers - Prospects From the Bench to the Clinic In: Cardona P-J, editor. Understanding Tuberculosis - Global Experiences and Innovative Approaches to the Diagnosis: InTech.
14. Kyeyune R, den Boon S, Cattamanchi A, Davis JL, Worodria W, et al. (2010) Causes of early mortality in HIV-infected TB suspects in an East African referral hospital. J Acquir Immune Defic Syndr 55: 446-450.
15. Worodria W, Davis JL, Cattamanchi A, Andama A, den Boon S, et al. (2010) Bronchoscopy is useful for diagnosing smear-negative tuberculosis in HIV-infected patients. Eur Respir J 36: 446-448.
16. Searle BCaT, Mark (2007) Improving Sensitivity by Combining Results from Multiple MS/MS Search Methodologies with the Scaffold Computer Algorithm. Portland, OR.
17. Keller A, Nesvizhskii AI, Kolker E, Aebersold R (2002) Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 74: 5383-5392. (Pubitemid 35215372)
18. Nesvizhskii AI, Keller A, Kolker E, Aebersold R (2003) A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 75: 4646-4658. (Pubitemid 37082259)
19. MacLean B, Tomazela DM, Shulman N, Chambers M, Finney GL, et al. (2010) Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 26: 966-968.
20. Maclean B, Tomazela DM, Abbatiello SE, Zhang S, Whiteaker JR, et al. (2010) Effect of collision energy optimization on the measurement of peptides by selected reaction monitoring (SRM) mass spectrometry. Anal Chem 82: 10116-10124.
21. Kruh NA, Troudt J, Izzo A, Prenni J, Dobos KM (2010) Portrait of a pathogen: the Mycobacterium tuberculosis proteome in vivo. PLoS One 5: e13938.
22. Izzo A, Brandt L, Lasco T, Kipnis AP, Orme I (2005) NIH pre-clinical screening program: overview and current status. Tuberculosis (Edinb) 85: 25-28. (Pubitemid 40431312)
23. Grover A, Taylor J, Troudt J, Keyser A, Sommersted K, et al. (2008) Mycobacterial infection induces the secretion of high-mobility group box 1 protein. Cellular microbiology 10: 1390-1404. (Pubitemid 351663928)
24. Sjogren M, Vanderstichele H, Agren H, Zachrisson O, Edsbagge M, et al. (2001) Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values. Clin Chem 47: 1776-1781. (Pubitemid 32881189)
25. Bartlett JW, Frost C, Mattsson N, Skillback T, Blennow K, et al. (2012) Determining cut-points for Alzheimer's disease biomarkers: statistical issues, methods and challenges. Biomark Med 6: 391-400.
26. Kruh-Garcia NA, Murray M, Prucha JG, Dobos KM (2013) Antigen 85 variation across lineages of Mycobacterium tuberculosis-Implications for vaccine and biomarker success. J Proteomics.
27. Picotti P, Rinner O, Stallmach R, Dautel F, Farrah T, et al. (2010) High-throughput generation of selected reaction-monitoring assays for proteins and proteomes. Nat Methods 7: 43-46.
28. Addona TA, Shi X, Keshishian H, Mani DR, Burgess M, et al. (2011) A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease. Nat Biotechnol 29: 635-643.
29. Jaffe JD, Keshishian H, Chang B, Addona TA, Gillette MA, et al. (2008) Accurate inclusion mass screening: a bridge from unbiased discovery to targeted assay development for biomarker verification. Mol Cell Proteomics 7: 1952- 1962.
30. Whiteaker JR, Lin C, Kennedy J, Hou L, Trute M, et al. (2011) A targeted proteomics-based pipeline for verification of biomarkers in plasma. Nat Biotechnol 29: 625-634.
31. Mehaffy C, Hess A, Prenni JE, Mathema B, Kreiswirth B, et al. (2010) Descriptive proteomic analysis shows protein variability between closely related clinical isolates of Mycobacterium tuberculosis. Proteomics 10: 1966-1984.
32. Kumar S, Puniya BL, Parween S, Nahar P, Ramachandran S (2013) Identification of novel adhesins of M. tuberculosis H37Rv using integrated approach of multiple computational algorithms and experimental analysis. PLoS One 8: e69790.
33. Forrellad MA, Klepp LI, Gioffre A, Sabio y Garcia J, Morbidoni HR, et al. (2013) Virulence factors of the Mycobacterium tuberculosis complex. Virulence 4: 3-66.
34. Voskuil MI, Bartek IL, Visconti K, Schoolnik GK (2011) The response of mycobacterium tuberculosis to reactive oxygen and nitrogen species. Frontiers in microbiology 2: 105.
35. Pandey R, Rodriguez GM (2012) A ferritin mutant of Mycobacterium tuberculosis is highly susceptible to killing by antibiotics and is unable to establish a chronic infection in mice. Infection and immunity 80: 3650-3659.
36. Reddy PV, Puri RV, Khera A, Tyagi AK (2012) Iron storage proteins are essential for the survival and pathogenesis of Mycobacterium tuberculosis in THP-1 macrophages and the guinea pig model of infection. Journal of bacteriology 194: 567-575.
37. Mustafa T, Wiker HG, Morkve O, Sviland L (2008) Differential expression of mycobacterial antigen MPT64, apoptosis and inflammatory markers in multinucleated giant cells and epithelioid cells in granulomas caused by Mycobacterium tuberculosis. Virchows Archiv : an international journal of pathology 452: 449-456.
38. Mustafa T, Wiker HG, Morkve O, Sviland L (2007) Reduced apoptosis and increased inflammatory cytokines in granulomas caused by tuberculous compared to non-tuberculous mycobacteria: role of MPT64 antigen in apoptosis and immune response. Clinical and experimental immunology 150: 105-113. (Pubitemid 47383306)
39. Kruh-Garcia NA SJaDK (2012) Exosomes: New Tuberculosis Biomarkers - Prospects From the Bench to the Clinic In: Cardona P-J, editor. Understanding Tuberculosis - Global Experiences and Innovative Approaches to the Diagnosis: InTech.